0002-3116-61 : NDC 2026 Code

0002-3116-61 : Mirikizumab-mrkz ( Omvoh )

Additionally :

You can get information about “0002-3116-61” NDC code in 0002-3116-61 in HTML format

HTML | 0002-3116-61 in TXT (Plain Text) format

TXT | 0002-3116-61 in PDF (Portable Document Format)

PDF | 0002-3116-61 in XML format

XML formats.

NDC Code : 0002-3116-61 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "0002-3116-61",
    "PackageDescription": "1 SYRINGE in 1 CARTON (0002-3116-61)  / 2 mL in 1 SYRINGE",
    "NDC11Code": "00002-3116-61",
    "ProductNDC": "0002-3116",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Omvoh",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Mirikizumab-mrkz",
    "DosageFormName": "INJECTION, SOLUTION",
    "RouteName": "SUBCUTANEOUS",
    "StartMarketingDate": "20251023",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761279",
    "LabelerName": "Eli Lilly and Company",
    "SubstanceName": "MIRIKIZUMAB",
    "StrengthNumber": "100",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-12-19",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20251106",
    "EndMarketingDatePackage": null,
    "SamplePackage": "Y"
  }
}